Rhabdomyosarcomas (RMS) are high-grade malignant tumors exhibiting partial myogenic differentiation due to aberrant expression of muscle regulatory factors (MRFs) such as myogenic factor 5 (MYF5), myoblast determination protein 1 (MYOD), and myogenin (MYOG)[1]. Here, MYOG is linked to cancer.